comparemela.com

Page 13 - Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hoffmann Green Cement Technologies: Hoffmann Green Signs a 6-year Partnership Agreement With Fondéole Group to Supply and Promote Hoffmann 0% Clinker Cements in the French Offshore and Onshore Wind Energy Markets

Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) ("Hoffmann Green Cement" or the "Company"), an industrial player committed to decarbonizing the construction

Pays de la loireThomas grojeanPierre laurentNicolas merigeauRegulatory newsGreen cement technologiesHoffmann green cement technologiesHoffmann greenWestern franceHoffmann green cementSyndicat des energies renouvelablesFinancial officerOnd 233 ole

F Hoffmann-La Roche Ltd: Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma

The PRAME (EPR20330) Antibody evaluates PRAME protein expression from patients with suspected melanoma. Understanding if the PRAME protein is expressed helps enable more informed clinical decisions and

United statesNew south walesSabine borngrGerard tobinBruno eschliBirgit masjostSileia urechThomas schineckerLoren kalmKarsten kleineNathalie altermattInternational academy of pathologyRoche groupWorld congressRoche group media relationsRabbit monoclonal primary antibody

F Hoffmann-La Roche Ltd: Roche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTU

Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which could significantly

United statesDaiichi sankyoSabine borngrGerard tobinBruno eschliBirgit masjostSileia urechThomas schineckerLoren kalmKarsten kleineNathalie altermattRoche groupDrug administrationRabbit monoclonal primaryRabbit monoclonalRabbit monoclonal primary antibody

F Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art 53 LR] Roche: Change in the Corporate Executive Committee in January 2023

Basel, 3 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Matt Sause (45), currently Head of Roche Diagnostics' North America Region, will become CEO Roche Diagnostics and a member

United statesSan diegoSouth koreaSeverin schwanThomas schineckerMatt sauseNathalie altermattUniversity of californiaDiagnostics divisionMiami universityRoche groupCorporate executive committeeRoche group media relationsRoche diagnostic north america regionLatin americaNorth america

F Hoffmann-La Roche Ltd: Change in the Roche Board of Directors

Basel, 26 September 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Julie Brown has notified the Board that she will step down as a member of the Roche Board of Directors as she has accepted

United statesJulie brownChristoph franzNathalie altermattRoche groupRoche group media relationsAudit committeeRoche boardPatrick frostAnnual general meetingChairman christoph franzDow jones sustainability indicesChugai pharmaceutical

vimarsana © 2020. All Rights Reserved.